THPO and Hepatic fibrosis: With the progression of liver fibrosis, serum AST activity increases due to its release from mitochondria and its diminished clearance; likewise, the platelet count decreases due to a hypo-production of thrombopoietin by the hepatocytes and an increased circulating platelet destruction in spleen, as portal hypertension develops.